MECHANICSBURG, Pa. and ADDISON, Texas, July 24, 2024 /PRNewswire/ — Select Medical Holdings Corporation (“Select Medical”) (NYSE: SEM) and Concentra Group Holdings Parent, Inc. (“Concentra”) (NYSE: CON), a wholly owned subsidiary of Select Medical, today announced the pricing of…
Month: July 2024
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sprinklr, Inc. (“Sprinklr” or the “Company”) (NYSE: CXM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sprinklr, Inc. (“Sprinklr” or the “Company”) (NYSE: CXM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Target Hospitality Corp. (“Target Hospitality” or the “Company”) (NASDAQ: TH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Target Hospitality Corp. (“Target Hospitality” or the “Company”) (NASDAQ: TH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Biomea Fusion, Inc. (“Biomea” or the “Company”) (NASDAQ: BMEA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Biomea Fusion, Inc. (“Biomea” or the “Company”) (NASDAQ: BMEA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. (“Cibus” or the “Company”) (NASDAQ: CBUS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. (“Cibus” or the “Company”) (NASDAQ: CBUS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Axos Financial, Inc. (“Axos” or the “Company”) (NYSE: AX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…